The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Sulforaphane inhibits histone deacetylase in vivo and suppresses tumorigenesis in Apc min mice
Open accessAbstract
Sulforaphane (SFN) is an isothiocyanate from broccoli that induces phase 2 detoxification enzymes. We recently reported that SFN acts as a histone deacetylase (HDAC) inhibitor in human colon cancer cells in vitro, and the present study sought to extend these findings in vivo. In mice treated with a single oral dose of 10 ümol SFN, there was significant inhibition of HDAC activity in the colonic mucosa after 6 h, and immunoblots revealed a concomitant increase in acetylated histones H3 and H4, which returned to control levels by 48 h. Longer‐term treatment with SFN in the diet resulted in levels of acetylated histones and p21 WAF1 in the ileum, colon, prostate, and peripheral blood mononuclear cells that were elevated compared with controls. Consistent with these findings, SFN suppressed tumor development in Apc min mice, and there was an increase in acetylated histones in the polyps, including acetylated histones specifically associated with the promoter region of the P21 and bax genes. These results provide the first evidence for HDAC inhibition by SFN in vivo and imply that such a mechanism might contribute to the cancer chemoprotective and therapeutic effects of SFN, alone or in combination with other HDAC inhibitors currently undergoing clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zhang, Y., Talalay, P., Cho, C. G., & Posner, G. H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.6.2399 · Cited by 1,682
Fahey, J. W., Zhang, Y., & Talalay, P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.19.10367 · Cited by 1,376
Ramos-Gomez, M., Kwak, M.-K., Dolan, P. M., Itoh, K., Yamamoto, M., Talalay, P., & Kensler, T. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051618798 · Cited by 1,102
Richon, V. M., Sandhoff, T. W., Rifkind, R. A., & Marks, P. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.180316197 · Cited by 1,090
Fahey, J. W., Haristoy, X., Dolan, P. M., Kensler, T. W., Scholtus, I., Stephenson, K. K., Talalay, P., & Lozniewski, A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.112203099 · Cited by 795
Zhang, Y., Kensler, T. W., Cho, C. G., Posner, G. H., & Talalay, P. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3147 · Cited by 745
Kelly, W. K., Richon, V. M., O’Connor, O. A., Curley, T., MacGregor‐Cortelli, B., Tong, W. P., Klang, M. G., Schwartz, L. B., Richardson, S., Rosa, E., et al. (2003) · PubMed · Cited by 624
Hinnebusch, B. F., Meng, S., Wu, J. T., Archer, S. Y., & Hodin, R. A. (2002) · The Journal of Nutrition · doi:10.1093/jn/132.5.1012 · Cited by 544
Nrf2, a multi‐organ protector?
Lee, J., Li, J., Johnson, D. A., Stein, T. D., Kraft, A. D., Calkins, M. J., Jakel, R. J., & Johnson, J. A. (2005) · The FASEB Journal · doi:10.1096/fj.04-2591hyp · Cited by 532
Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis
Zhu, P., Martin, E., Mengwasser, J., Schlag, P., Janssen, K.-P., & Göttlicher, M. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00114-x · Cited by 525
The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2
Krämer, O. H., Zhu, P., Ostendorff, H. P., Golebiewski, M., Tiefenbach, J., Peters, M. A., Brill, B., Groner, B., Bach, I., Heinzel, T., et al. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg315 · Cited by 523 · cited 1×
“Valproic acid is a somewhat unique HDAC inhibitor in that it shows specificity for Class I HDACs and targets HDAC2 for proteosomal degradation (33, 34), resulting in both inhibition of existing HDACs and reduction in HDAC protein levels.”
BackgroundSandor, V. A., Bakke, S., Robey, R. W., Kang, M. H., Blagosklonny, M. V., Bender, J., Brooks, R. A., Piekarz, R., Tucker, E. E., Figg, W. D., et al. (2002) · PubMed · Cited by 502
A Novel Mechanism of Chemoprotection by Sulforaphane
Myzak, M. C., Karplus, P. A., Chung, F.-L., & Dashwood, R. H. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1326 · Cited by 494
Self-citationEggler, A. L., Liu, G., Pezzuto, J. M., van Breemen, R. B., & Mesecar, A. D. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502402102 · Cited by 456
Mariadason, J. M., Corner, G. A., & Augenlicht, L. H. (2000) · PubMed · Cited by 375
Satelite Symposium V, Meet-the-Professor Sessions I and II, Main Sessions I-IX
(2004) · Annals of Hematology · doi:10.1007/s00277-004-0850-2 · Cited by 365
Chung, F.-L. (2000) · Carcinogenesis · doi:10.1093/carcin/21.12.2287 · Cited by 350
Carotenoids activate the antioxidant response element transcription system
Ben-Dor, A., Steiner, M., Gheber, L., Danilenko, M., Dubi, N., Linnewiel, K., Zick, A., Sharoni, Y., & Levy, J. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.177.4.1 · Cited by 319
DIETARY FACTORS IN HUMAN COLORECTAL CANCER
Lipkin, M., Reddy, B., Newmark, H., & Lamprecht, S. A. (1999) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.19.1.545 · Cited by 305
Druesne, N. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh123 · Cited by 254
Glutathione transferase null genotype, broccoli, and lower prevalence of colorectal adenomas.
Lin, H. J., Probst-Hensch, N. M., Louie, A. D., Kau, I. H., Witte, J. S., Ingles, S. A., Frankl, H. D., Lee, E. R., & Haile, R. W. (1998) · PubMed · Cited by 228
Seow, A. (2002) · Carcinogenesis · doi:10.1093/carcin/23.12.2055 · Cited by 227
Zhu, W.-G., & Otterson, G. (2003) · Current Medicinal Chemistry-Anti-Cancer Agents · doi:10.2174/1568011033482440 · Cited by 226
Chemoprotection by sulforaphane: Keep one eye beyond Keap1
Myzak, M. C., & Dashwood, R. H. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.02.033 · Cited by 173
Self-citationMcBain, J. A., Eastman, A., Nobel, C. S., & Mueller, G. C. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(96)00904-5 · Cited by 165
Myzak, M., & Dashwood, R. (2006) · Current Drug Targets · doi:10.2174/138945006776359467 · Cited by 160
Self-citationGenes modulated by histone acetylation as new effectors of butyrate activity
Ragione, F. D., Criniti, V., Pietra, V. D., Borriello, A., Oliva, A., Indaco, S., Yamamoto, T., & Zappia, V. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02539-x · Cited by 148
Remiszewski, S., Sambucetti, L. C., Atadja, P. W., Bair, K. W., Cornell, W. D., Green, M. A., Howell, K. L., Jung, M., Kwon, P. O., Trogani, N., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm015568c · Cited by 113
Finzer, P., Kuntzen, C., Soto, U., Hausen, H. Z., & Rösl, F. (2001) · Oncogene · doi:10.1038/sj.onc.1204652 · Cited by 112
Dashwood, R. H. (2002) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(02)00005-4 · Cited by 96
Self-citationReddy, B. S. (2000) · PubMed · Cited by 94
Chen, Z., Clark, S., Birkeland, M., Sung, C.-M., Lago, A., Liu, R., Kirkpatrick, R., Johanson, K., Winkler, J. D., & Hu, E. (2002) · Cancer Letters · doi:10.1016/s0304-3835(02)00322-1 · Cited by 87
Yoxall, V., Kentish, P., Coldham, N. G., Kuhnert, N., Sauer, M. J., & Ioannides, C. (2005) · International Journal of Cancer · doi:10.1002/ijc.21191 · Cited by 81
Lavelle, D., Chen, Y., Hankewych, M., & DeSimone, J. (2001) · American Journal of Hematology · doi:10.1002/ajh.1174 · Cited by 81
Woo, S. H., Fréchette, S., Khalil, E. A., Bouchain, G., Vaisburg, A., Bernstein, N., Moradei, O. M., Leit, S. M., Allan, M., Fournel, M., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020154k · Cited by 73
Eickhoff, B., Rüller, S., Laue, T., Köhler, G., Stahl, C., Schlaak, M. S., & van der Bosch, J. (2000) · Biological Chemistry · doi:10.1515/bc.2000.015 · Cited by 50
Yang, K. (2003) · Carcinogenesis · doi:10.1093/carcin/24.3.605 · Cited by 48
Kobayashi, H., Tan, E. M., & Fleming, S. E. (2003) · International Journal of Cancer · doi:10.1002/ijc.11697 · Cited by 36
Cited by
Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis
HIGDON, J., DELAGE, B., WILLIAMS, D., & DASHWOOD, R. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.01.009 · Cited by 1,039
Self-citationHistone deacetylases and cancer
Glozak, M. A., & Seto, E. (2007) · Oncogene · doi:10.1038/sj.onc.1210610 · Cited by 1,031
The cytoprotective role of the Keap1–Nrf2 pathway
Baird, L., & Dinkova-Kostova, A. T. (2011) · Archives of Toxicology · doi:10.1007/s00204-011-0674-5 · Cited by 1,027
The tumour microenvironment as a target for chemoprevention
Albini, A., & Sporn, M. B. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2067 · Cited by 823
Molecular basis for chemoprevention by sulforaphane: a comprehensive review
Juge, N., Mithen, R. F., & Traka, M. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-6484-5 · Cited by 693
Metadata
- Authors
- Myzak, M. C., Dashwood, W. M., Orner, G. A., Ho, E., & Dashwood, R. H.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2006-01-11
- Volume
- 20
- Issue
- 3
- Pages
- 506-508
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2128428442
- Cited by
- 344
- References
- 38
- FWCI
- 7.98
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.